Dox Uptakes Of Single K562 Cells Treated With 1 M Dox For 3 H

DOX uptakes of single K562 cells treated with 1 μM DOX for 3 h ...
DOX uptakes of single K562 cells treated with 1 μM DOX for 3 h ...
DOX uptakes of single K562 cells treated with 1 μM DOX for 3 h ...
DOX uptakes of single K562 cells treated with 1 μM DOX for 3 h ...
DOX uptakes of single K562 cells treated with 1 μM DOX for 3 h ...
DOX uptakes of single K562 cells treated with 1 μM DOX for 3 h ...
(A) K562 cells treated with 50 nM of DOX for 4 days were stained for ...
(A) K562 cells treated with 50 nM of DOX for 4 days were stained for ...
(A) K562 cells treated with 50 nM of DOX for 4 days were stained for ...
(A) K562 cells treated with 50 nM of DOX for 4 days were stained for ...
a – b Mean fluorescence intensity of DOX uptake by single K562 cells ...
a – b Mean fluorescence intensity of DOX uptake by single K562 cells ...
a – b The RSD% for the DOX uptake of single K562 cells, derived using ...
a – b The RSD% for the DOX uptake of single K562 cells, derived using ...
-Viability of K562/ADR cells treated with (A) DOX HCl, PIDA and PIDA ...
-Viability of K562/ADR cells treated with (A) DOX HCl, PIDA and PIDA ...
DOX uptake amounts in single K562 cells derived using CE-LIF. The cells ...
DOX uptake amounts in single K562 cells derived using CE-LIF. The cells ...
a – b Mean DOX uptake of single K562 cells, derived using CE-LIF, as ...
a – b Mean DOX uptake of single K562 cells, derived using CE-LIF, as ...
DOX uptake amounts in single K562 cells derived using CE-LIF. The cells ...
DOX uptake amounts in single K562 cells derived using CE-LIF. The cells ...
The sensitivity of K562 and K562/DOX cells to DOX and balaglitazone ...
The sensitivity of K562 and K562/DOX cells to DOX and balaglitazone ...
The sensitivity of K562 and K562/DOX cells to DOX and balaglitazone ...
The sensitivity of K562 and K562/DOX cells to DOX and balaglitazone ...
a – b Mean DOX uptake of single K562 cells, derived using CE-LIF, as ...
a – b Mean DOX uptake of single K562 cells, derived using CE-LIF, as ...
Morphological changes of (A) K562 and (B) MCF-7 cells treated with ...
Morphological changes of (A) K562 and (B) MCF-7 cells treated with ...
Cell survival of transfected K562 cells treated with OA. (a) K562 cells ...
Cell survival of transfected K562 cells treated with OA. (a) K562 cells ...
Morphological changes of (A) K562 and (B) MCF-7 cells treated with ...
Morphological changes of (A) K562 and (B) MCF-7 cells treated with ...
Effect of rhTNF-NC on PKCα Expression in K562/ Dox Cells Note: A: K562 ...
Effect of rhTNF-NC on PKCα Expression in K562/ Dox Cells Note: A: K562 ...
(A) K562 cells were treated as indicated for measurement of ...
(A) K562 cells were treated as indicated for measurement of ...
(a-b) Transport of DOX into the K562 cell nuclei. Cells were incubated ...
(a-b) Transport of DOX into the K562 cell nuclei. Cells were incubated ...
Cell viability of K562 incubated with DOX (0.5 μg/mL) and different ...
Cell viability of K562 incubated with DOX (0.5 μg/mL) and different ...
Cell viability of K562 cells treated with different concentrations of ...
Cell viability of K562 cells treated with different concentrations of ...
The sensitivity of K562 and K562/DOX cells to DOX and balaglitazone ...
The sensitivity of K562 and K562/DOX cells to DOX and balaglitazone ...
Cell viability of K562 cells treated with Doxorubicin. (a) Cell ...
Cell viability of K562 cells treated with Doxorubicin. (a) Cell ...
Silencing of S100A8 increases the sensitivity of K562/DOX cells to DOX ...
Silencing of S100A8 increases the sensitivity of K562/DOX cells to DOX ...
Silencing of S100A8 increases the sensitivity of K562/DOX cells to DOX ...
Silencing of S100A8 increases the sensitivity of K562/DOX cells to DOX ...
DOX-induced cytotoxicity in K562 erythroleukemia cells treated with ...
DOX-induced cytotoxicity in K562 erythroleukemia cells treated with ...
The morphological changes of K562 and KG1-a cells after treatment with ...
The morphological changes of K562 and KG1-a cells after treatment with ...
Cytotoxicity of different combinations of DOX in K562 and K562/DOX ...
Cytotoxicity of different combinations of DOX in K562 and K562/DOX ...
Enhanced erythroid differentiation of K562 cells observed for ...
Enhanced erythroid differentiation of K562 cells observed for ...
Cytotoxicity of different combinations of DOX in K562 and K562/DOX ...
Cytotoxicity of different combinations of DOX in K562 and K562/DOX ...
Analysis of doxorubicin uptake in single human leukemia K562 cells ...
Analysis of doxorubicin uptake in single human leukemia K562 cells ...
Cellular quantification of doxorubicin. (A) Cells treated with free ...
Cellular quantification of doxorubicin. (A) Cells treated with free ...
Effects of DOX and STI571 used alone or in combination on K562 cell ...
Effects of DOX and STI571 used alone or in combination on K562 cell ...
% ATP change of treated K562 and K562/Dox cancer cells and non-treated ...
% ATP change of treated K562 and K562/Dox cancer cells and non-treated ...
Sensitization of K562R cells by co-treatment of DOX and different ...
Sensitization of K562R cells by co-treatment of DOX and different ...

Loading image details...

Source
Dimensions